Safety Report: Umary Hyaluronic Acid tablets - recalled due to diclofenac and omeprazole, USA

United States

MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC to the consumer level. The products have been found to have omeprazole and diclofenac. FDA laboratory analysis confirmed that Umary contains diclofenac and omeprazole. UMARY has been distributed across the USA Via Amazon.

Risk Statement: The product Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). NSAIDs may cause an increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.

Omeprazole is a proton pump inhibitor (commonly referred to as PPI) used to treat gastric (stomach) acid-related disorders. PPI medicines may cause serious skin reactions. This hidden ingredient may mask stomach issues such as erosion, ulcers, and stomach cancer, and it can also interact with other medications and should not be taken with certain medications.

The product is used as a dietary supplement and is packaged in a plastic container, UMARY ACID HYALURONIC, 30 CAPLETS 850 MG. The affected UMARY Acid hyaluronic. UPC:7502265120323 lots include the following Lot number: 24183 and the expiration date: 07/01/24. 321 units were distributed.

Consumers/distributors/retailers that have Umary which is being recalled should stop using/return to the place of purchase for a full refund.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: MXBBB
Brand name: Umary
Product recalled: UMARY Hyaluronic Acid tablets
Reason for the recall: The product contains undeclared diclofenac and omeprazole
FDA Recall date: November 20, 2024

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mxbbb-issues-voluntary-nationwide-recall-umary-acid-hyaluronic-due-presence-diclofenac-and